228 related articles for article (PubMed ID: 24936795)
21. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
Singh R; Stockard CR; Grizzle WE; Lillard JW; Singh S
Int J Oncol; 2011 Aug; 39(2):373-81. PubMed ID: 21637913
[TBL] [Abstract][Full Text] [Related]
22. Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13.
Camelo A; Barlow JL; Drynan LF; Neill DR; Ballantyne SJ; Wong SH; Pannell R; Gao W; Wrigley K; Sprenkle J; McKenzie AN
J Gastroenterol; 2012 Nov; 47(11):1198-211. PubMed ID: 22539101
[TBL] [Abstract][Full Text] [Related]
23. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.
Amersi FF; Terando AM; Goto Y; Scolyer RA; Thompson JF; Tran AN; Faries MB; Morton DL; Hoon DS
Clin Cancer Res; 2008 Feb; 14(3):638-45. PubMed ID: 18245522
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum.
Ullah M; Eucker J; Sittinger M; Ringe J
Stem Cell Res Ther; 2013 Aug; 4(4):99. PubMed ID: 23958031
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.
Abd Alla J; Langer A; Elzahwy SS; Arman-Kalcek G; Streichert T; Quitterer U
J Biol Chem; 2010 Jul; 285(30):23496-505. PubMed ID: 20504763
[TBL] [Abstract][Full Text] [Related]
26. Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis.
Rivera-Nieves J; Ho J; Bamias G; Ivashkina N; Ley K; Oppermann M; Cominelli F
Gastroenterology; 2006 Nov; 131(5):1518-29. PubMed ID: 17101325
[TBL] [Abstract][Full Text] [Related]
27. CCR9 and CCL25: A review of their roles in tumor promotion.
Xu B; Deng C; Wu X; Ji T; Zhao L; Han Y; Yang W; Qi Y; Wang Z; Yang Z; Yang Y
J Cell Physiol; 2020 Dec; 235(12):9121-9132. PubMed ID: 32401349
[TBL] [Abstract][Full Text] [Related]
28. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
[TBL] [Abstract][Full Text] [Related]
29. C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice.
Amiya T; Nakamoto N; Irie J; Taniki N; Chu PS; Koda Y; Miyamoto K; Yamaguchi A; Shiba S; Morikawa R; Itoh H; Kanai T
Diabetologia; 2021 Mar; 64(3):603-617. PubMed ID: 33399911
[TBL] [Abstract][Full Text] [Related]
30. Characterization of CCR9 expression and CCL25/thymus-expressed chemokine responsiveness during T cell development: CD3(high)CD69+ thymocytes and gammadeltaTCR+ thymocytes preferentially respond to CCL25.
Uehara S; Song K; Farber JM; Love PE
J Immunol; 2002 Jan; 168(1):134-42. PubMed ID: 11751956
[TBL] [Abstract][Full Text] [Related]
31. STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines.
Rosen MJ; Chaturvedi R; Washington MK; Kuhnhein LA; Moore PD; Coggeshall SS; McDonough EM; Weitkamp JH; Singh AB; Coburn LA; Williams CS; Yan F; Van Kaer L; Peebles RS; Wilson KT
J Immunol; 2013 Feb; 190(4):1849-58. PubMed ID: 23303670
[TBL] [Abstract][Full Text] [Related]
32. CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation.
López-Pacheco C; Soldevila G; Du Pont G; Hernández-Pando R; García-Zepeda EA
Mediators Inflamm; 2016; 2016():3635809. PubMed ID: 27795621
[TBL] [Abstract][Full Text] [Related]
33. Expression of CCR9 beta-chemokine receptor is modulated in thymocyte differentiation and is selectively maintained in CD8(+) T cells from secondary lymphoid organs.
Carramolino L; Zaballos A; Kremer L; Villares R; Martín P; Ardavín C; Martínez-A C; Márquez G
Blood; 2001 Feb; 97(4):850-7. PubMed ID: 11159507
[TBL] [Abstract][Full Text] [Related]
34. CCR9 signaling in dendritic cells drives the differentiation of Foxp3
Pathak M; Padghan P; Halder N; Shilpi ; Kulkarni N; Sonar SA; Lal G
Eur J Immunol; 2020 Mar; 50(3):404-417. PubMed ID: 31755547
[TBL] [Abstract][Full Text] [Related]
35. Expression of TECK/CCL25 and MEC/CCL28 chemokines and their respective receptors CCR9 and CCR10 in porcine mucosal tissues.
Meurens F; Berri M; Whale J; Dybvig T; Strom S; Thompson D; Brownlie R; Townsend HG; Salmon H; Gerdts V
Vet Immunol Immunopathol; 2006 Oct; 113(3-4):313-27. PubMed ID: 16839611
[TBL] [Abstract][Full Text] [Related]
36. V alpha 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement.
Sen Y; Yongyi B; Yuling H; Luokun X; Li H; Jie X; Tao D; Gang Z; Junyan L; Chunsong H; Zhang X; Youxin J; Feili G; Boquan J; Jinquan T
J Immunol; 2005 Oct; 175(8):4914-26. PubMed ID: 16210593
[TBL] [Abstract][Full Text] [Related]
37. The murine DCs transfected with DNA-plasmid encoding CCR9 demonstrate the increased migration to CCL25 and thymic cells in vitro and to the thymus in vivo.
Tereshchenko V; Bulygin A; Zavodskii R; Maksyutov A; Kurilin V; Fisher M; Semenyuk N; Aladev S; Sennikov S
Cytokine; 2021 Jun; 142():155473. PubMed ID: 33647585
[TBL] [Abstract][Full Text] [Related]
38. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
[TBL] [Abstract][Full Text] [Related]
39. Commensal bacteria and expression of two major intestinal chemokines, TECK/CCL25 and MEC/CCL28, and their receptors.
Meurens F; Berri M; Siggers RH; Willing BP; Salmon H; Van Kessel AG; Gerdts V
PLoS One; 2007 Jul; 2(7):e677. PubMed ID: 17653288
[TBL] [Abstract][Full Text] [Related]
40. The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes.
Atanes P; Lee V; Huang GC; Persaud SJ
Metabolism; 2020 Dec; 113():154394. PubMed ID: 33058852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
